Literature DB >> 2723637

Effect of dichloroacetate on regional energy metabolites and pyruvate dehydrogenase activity during ischemia and reperfusion in gerbil brain.

Y Katayama1, F A Welsh.   

Abstract

The objective of this study was to determine whether administration of dichloroacetate (DCA), an activator of pyruvate dehydrogenase (PDH), improves recovery of energy metabolites following transient cerebral ischemia. Gerbils were pretreated with DCA, and cerebral ischemia was produced using bilateral carotid artery occlusion for 20 min, followed by reperfusion up to 4 h. DCA had no effect on the accumulation of lactic acid and the decrease in ATP and phosphocreatine (PCr) during the 20-min insult, nor on the recovery of these metabolites measured at 20 and 60 min reperfusion. However, at 4 h reperfusion, levels of ATP and PCr were significantly higher in DCA-treated animals than in controls, as PCr exhibited a secondary decrease in caudate nucleus of control animals. PDH was markedly inhibited at 20 min reperfusion in both groups, but was reactivated to a greater extent in DCA-treated animals at 60 min and 4 h reperfusion. These results demonstrate that DCA had no effect on the initial recovery of metabolites following transient ischemia. However, later in reperfusion, DCA enhanced the postischemic reactivation of PDH and prevented the secondary failure of energy metabolism in caudate nucleus. Thus, inhibition of PDH may limit the recovery of energy metabolism following cerebral ischemia.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2723637     DOI: 10.1111/j.1471-4159.1989.tb07262.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  11 in total

Review 1.  Calcium, energy metabolism and the development of selective neuronal loss following short-term cerebral ischemia.

Authors:  N R Sims
Journal:  Metab Brain Dis       Date:  1995-09       Impact factor: 3.584

2.  Dichloroacetate increases glucose use and decreases lactate in developing rat brain.

Authors:  A L Miller; J P Hatch; T J Prihoda
Journal:  Metab Brain Dis       Date:  1990-12       Impact factor: 3.584

Review 3.  Pyruvate dehydrogenase complex: metabolic link to ischemic brain injury and target of oxidative stress.

Authors:  Erica Martin; Robert E Rosenthal; Gary Fiskum
Journal:  J Neurosci Res       Date:  2005 Jan 1-15       Impact factor: 4.164

4.  Dichloroacetate attenuates neuronal damage in a gerbil model of brain ischemia.

Authors:  R V Dimlich; P J Marangos
Journal:  J Mol Neurosci       Date:  1994       Impact factor: 3.444

Review 5.  Energy metabolism and selective neuronal vulnerability following global cerebral ischemia.

Authors:  N R Sims
Journal:  Neurochem Res       Date:  1992-09       Impact factor: 3.996

6.  Acetyl-L-carnitine attenuates neuronal damage in gerbils with transient forebrain ischemia only when given before the insult.

Authors:  A Shuaib; T Waqaar; T Wishart; R Kanthan; W Howlett
Journal:  Neurochem Res       Date:  1995-09       Impact factor: 3.996

7.  The role of cytosolic free calcium in the regulation of pyruvate dehydrogenase in synaptosomes.

Authors:  H M Huang; L Toral-Barza; K F Sheu; G E Gibson
Journal:  Neurochem Res       Date:  1994-01       Impact factor: 3.996

8.  Probucol attenuates oxidative stress, energy starvation, and nitric acid production following transient forebrain ischemia in the rat hippocampus.

Authors:  Abdulhakeem A Al-Majed
Journal:  Oxid Med Cell Longev       Date:  2011-08-04       Impact factor: 6.543

9.  Dichloroacetate treatment improves mitochondrial metabolism and reduces brain injury in neonatal mice.

Authors:  Yanyan Sun; Tao Li; Cuicui Xie; Yaodong Zhang; Kai Zhou; Xiaoyang Wang; Klas Blomgren; Changlian Zhu
Journal:  Oncotarget       Date:  2016-05-31

Review 10.  Mitochondria, Bioenergetics and Excitotoxicity: New Therapeutic Targets in Perinatal Brain Injury.

Authors:  Bryan Leaw; Syam Nair; Rebecca Lim; Claire Thornton; Carina Mallard; Henrik Hagberg
Journal:  Front Cell Neurosci       Date:  2017-07-12       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.